Literature DB >> 8405860

Serology of acute exacerbation in chronic hepatitis B virus infection.

T Maruyama1, S Iino, K Koike, K Yasuda, D R Milich.   

Abstract

BACKGROUND: Liver injury in many patients with chronic hepatitis B is sporadic and is often characterized by acute exacerbations alternating with relatively normal liver function. The aim of this study was to perform detailed serological and biochemical analysis during periods of active liver disease to better understand the mechanisms responsible for the cyclic nature of liver injury.
METHODS: A series of serum samples from 19 hepatitis B e antigen (HBeAg)-positive patients were analyzed for alterations in serum hepatitis B virus (HBV) DNA, HBeAg, anti-HBe production, and HBeAg-specific immune complex formation before, during, and after spontaneous acute exacerbations of liver injury.
RESULTS: This analysis revealed significant correlations between increasing levels of serum HBV DNA, HBeAg, HBeAg-specific immune complexes, and liver injury. These results suggest that increases in viral replication and accumulation of viral proteins in the serum and intracellularly and the subsequent immune response play an important role in initiating acute exacerbations of liver injury in chronic hepatitis B infection.
CONCLUSIONS: We propose that production of the secreted and cellular forms of the nucleoprotein reaches a threshold level and elicits specific immune responses, which mediate liver injury.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8405860     DOI: 10.1016/0016-5085(93)90960-k

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  19 in total

Review 1.  Immunopathogenesis of viral hepatitis.

Authors:  M U Mondelli
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

2.  Acute pancreatitis complicating spontaneous acute exacerbation of chronic hepatitis B virus infection: case report and review of the literature.

Authors:  Kyo-Sang Yoo; Kyung-Hun Lee; Kyung Rim Huh; Won Sub Choi; Gang Jeon; Jun-Wook Ha; Kyoung Oh Kim; Cheol Hee Park; Taeho Hahn; Sang Hoon Park; Jong Hyeok Kim; Choong Kee Park
Journal:  Gut Liver       Date:  2009-03-31       Impact factor: 4.519

3.  Reversal of B-cell hyperactivation and functional impairment is associated with HBsAg seroconversion in chronic hepatitis B patients.

Authors:  Xiangsheng Xu; Qinghua Shang; Xinyue Chen; Weimin Nie; Zhengsheng Zou; Ang Huang; Ming Meng; Lei Jin; Ruonan Xu; Ji-Yuan Zhang; Junliang Fu; Lifeng Wang; Zirong Tang; Yunbo Xie; Xiaoming Yang; Zheng Zhang; Fu-Sheng Wang
Journal:  Cell Mol Immunol       Date:  2015-04-06       Impact factor: 11.530

4.  Association Between Severe Serum Alanine Aminotransferase Flares and Hepatitis B e Antigen Seroconversion and HBV DNA Decrease in Untreated Patients With Chronic HBV Infection.

Authors:  Mayur Brahmania; Manuel Lombardero; Bettina E Hansen; Norah A Terrault; Anna S Lok; Robert P Perrillo; Steven H Belle; Adrian M Di Bisceglie; Jordan J Feld; William M Lee; Michael W Fried; Harry L A Janssen
Journal:  Clin Gastroenterol Hepatol       Date:  2019-02-08       Impact factor: 11.382

5.  Antibodies to the hepatitis B e antigen (HBeAg) can be induced in HBeAg-transgenic mice by adoptive transfer of a specific T-helper 2 cell clone.

Authors:  C Hultgren; D R Milich; M Sällberg
Journal:  Clin Diagn Lab Immunol       Date:  1997-09

6.  Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B.

Authors:  S Rossol; G Marinos; P Carucci; M V Singer; R Williams; N V Naoumov
Journal:  J Clin Invest       Date:  1997-06-15       Impact factor: 14.808

Review 7.  Acute exacerbation of chronic hepatitis B: the dilemma of differentiation from acute viral hepatitis B.

Authors:  Pankaj Puri
Journal:  J Clin Exp Hepatol       Date:  2013-10-17

8.  Spontaneous seroconversion in chronic hepatitis B: role of mutations in the precore/core gene.

Authors:  E Schulte-Frohlinde; G R Foster
Journal:  Dig Dis Sci       Date:  1998-08       Impact factor: 3.199

9.  Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B.

Authors:  C Boni; A Bertoletti; A Penna; A Cavalli; M Pilli; S Urbani; P Scognamiglio; R Boehme; R Panebianco; F Fiaccadori; C Ferrari
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

10.  Hepatitis B virus e antigen loss during adefovir dipivoxil therapy is associated with enhanced virus-specific CD4+ T-cell reactivity.

Authors:  Helen Cooksley; Shilpa Chokshi; Yafit Maayan; Heiner Wedemeyer; Pietro Andreone; Richard Gilson; Thomas Warnes; Simona Paganin; Fabien Zoulim; David Frederick; Avidan U Neumann; Carol L Brosgart; Nikolai V Naoumov
Journal:  Antimicrob Agents Chemother       Date:  2007-11-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.